Plasminogen activators released from cancer cells may catalyze the proteolytic conversion of the inactive zymogen plasminogen to the active protease plasmin, which in turn catalyzes degradation of proteins in basement membranes and extracellular matrix (ECM) and thus facilitates cancer cell invasion into the surrounding tissue. The gene discussed is PLG; the disease is cancer.